Bharat Book Bureau Provides the Trending Market Research Report on Global Biosimilars Market Opportunity Analysis And Industry Forecast 2017-2023 Under Life Science category. The report provides information on industry overview, market size, latest developments, industry trends, key players, global presence, and their future prospects.
Biosimilars Market : By-Drug Class (Monoclonal Antibodies, Recombinant Hormones, Recombinant Growth Factors, Immunomodulators, Anti-Inflammatory Agents, and Others), By Application (Oncology, Blood Disorders, Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Diabetes, and others) Others), By Manufacturing Type (Captive and Outsourcing), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Biosimilars Market Report Description:
Global biosimilars market report gives a comprehensive outlook on biosimilars products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on biosimilars market gives historical, current, and future market sizes (US $ Mn) on the basis of product type, application, manufacturing type, distribution channel, and geographic regions. This report studies biosimilars market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, biosimilars market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition. More over, PBI analyzed biosimilars market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot Spots) and market unmet needs (Product Opportunities). Key stakeholders of the biosimilars market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in manufacturing, supplying and prescribing biosimilar products.
Request a free sample copy of Biosimilars Market Report @
https://www.bharatbook.com/request-sample/626422
Global Biosimilars Market:
Global biosimilars market estimated to be valued US $ 4.10 Bn in 2017 and poised to grow at CAGR of 23.0% over 2017-2023. A market for biosimilars projected to reach US $ 14.23 Bn by 2023 owing to increasing biosimilars product pipeline.
Growing demand for cost-effective health care is driving the market revenue growth
Global biosimilars market is gaining traction in recent times owing to its cost-effective pricing in comparison with patented or branded biologics, which are generally priced higher than biologics. The adoption of cost-effective biosimilars is growing in different healthcare settings across the developing and developing countries. The introduction of biosimilars has led to improved access to premium-priced biopharmaceuticals in developing and underdeveloped markets with lesser costs. Moreover, favorable government policies to promote cost-effective biosimilars.
Increasing prevalence of several chronic diseases are expected to drive biosimilars
The rising prevalence of several chronic diseases such as cancer, diabetes, cardiovascular diseases, autoimmune disease, and others is expected to increase the market for biosimilars. The growing demand from developing and underdeveloped market for improved healthcare access are driving the market revenue growth over the forecast period. Moreover, several players are looking to tap into the growing market. For example, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide.
Europe emerged as a prominent region for biosimilars across the globe
Share in a global biosimilars market. Asia-Pacific biosimilars projected to grow at high risk.
Competition Assessment
Key players profiled in the global biosimilars market include:
– Amgen Inc. (US)
– Biocon Ltd. (India)
– Celltrion, Inc. (South Korea)
– Dr Reddy’s Laboratories Ltd. (India)
– F. Hoffmann-La Roche Ltd. (Switzerland)
– Pfizer Inc. (US)
– Samsung Bioepis (South Korea)
– Novartis AG (Switzerland)
– Teva Pharmaceuticals Industries Ltd. (Israel)
Players in biosimilars market are focusing on introducing low-cost biosimilars into developed and developing economies to garner larger market revenues. Share in global biosimilars market. For instance, in 2015 Sandoz (Novartis AG) launched generic version (Glatopa) of copaxone (glatiramer acetate) in US market.
Browse our full report with Table of Contents:
https://www.bharatbook.com/healthcare-market-research-reports-626422/biosimilars-global-estimation.html
About Bharat Book Bureau:
Bharat Book Bureau is a leading research information provider for market research reports, company profiles, industry reports, country reports, business reports, newsletters and online databases. Bharat Book Bureau delivers more than 400 publishers around the globe. We cover ourselves from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel : +91 22 27810772/27810773
Email : poonam@bharatbook.com
Website : www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus